2026 ICD-10-CM Diagnosis Code C83.7ABurkitt lymphoma, in remission

ICD-10-CM Codes›C00–D49›C81-C96›C83

ICD-10-CM C83.7A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C83.7A is a billable ICD-10-CM diagnosis code for burkitt lymphoma, in remission. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842, 974 through 976. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Non-Hodgkin lymphoma in remission.

Code Identity

ICD-10-CM Code
C83.7A
Billable Status
Yes — Valid for Submission
Code Describes
Burkitt lymphoma, in remission
Short Description
Burkitt lymphoma, in remission
Same as the full description in the CMS dataset.
Parent Code
C83.7
Burkitt lymphoma

Code Classification

ChapterC00–D49Neoplasms
SectionC81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue
CategoryC83Non-follicular lymphoma
This CodeC83.7ABurkitt lymphoma, in remission

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO077
Non-Hodgkin lymphoma in remission
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Burkitt Lymphoma

    a form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world. it is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. b-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma. the epstein-barr virus (herpesvirus 4, human) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however, most non-african cases are ebv-negative.

  • Herpesvirus 4, Human

    the type species of lymphocryptovirus, subfamily gammaherpesvirinae, infecting b-cells in humans. it is thought to be the causative agent of infectious mononucleosis and is strongly associated with oral hairy leukoplakia (leukoplakia, hairy;), burkitt lymphoma; and other malignancies.

  • Receptors, CXCR5

    cxcr receptors isolated initially from burkitt lymphoma cells. cxcr5 receptors are expressed on mature, recirculating b-lymphocytes and are specific for chemokine cxcl13.

Code History & ChangesHistory

Replacement C83.7A replaces the following previously assigned code(s):

  • Z85.72 - Personal history of non-Hodgkin lymphomas
FY 2025AddedAdded to the ICD-10-CM code setEffective October 1, 2024.
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C83.7AOverview

Is C83.7A (Burkitt lymphoma) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report burkitt lymphoma, in remission on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C83.7A group to?

When burkitt lymphoma, in remission is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, 974, 975, 976, with relative weights from 0.8945 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.